K. Kawase, Kazuhiko Yoshida, Keigo Hara, Suguru Hidaka, H. Takeyama
{"title":"纳米颗粒白蛋白结合紫杉醇和FEC治疗人表皮生长因子受体2阳性乳腺癌新辅助化疗的疗效和安全性","authors":"K. Kawase, Kazuhiko Yoshida, Keigo Hara, Suguru Hidaka, H. Takeyama","doi":"10.52845/cmi/2023-4-2-1","DOIUrl":null,"url":null,"abstract":".","PeriodicalId":7667,"journal":{"name":"African Research Review","volume":"90 1-2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Neoadjuvant Chemotherapy with Dose De-Escalation Tri-Weekly Nanoparticle Albumin-Bound Paclitaxel and FEC for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer\",\"authors\":\"K. Kawase, Kazuhiko Yoshida, Keigo Hara, Suguru Hidaka, H. Takeyama\",\"doi\":\"10.52845/cmi/2023-4-2-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\".\",\"PeriodicalId\":7667,\"journal\":{\"name\":\"African Research Review\",\"volume\":\"90 1-2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"African Research Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52845/cmi/2023-4-2-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Research Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52845/cmi/2023-4-2-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy and Safety of Neoadjuvant Chemotherapy with Dose De-Escalation Tri-Weekly Nanoparticle Albumin-Bound Paclitaxel and FEC for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
